<DOC>
	<DOCNO>NCT02910141</DOCNO>
	<brief_summary>This study aim compare glycaemic control continuous subcutaneous insulin fusion ( CSII , insulin pump therapy ) multiple daily insulin injection type 2 diabetes identify patient-level characteristic predict best improvement control change insulin dose outcome .</brief_summary>
	<brief_title>Individual Patient Data Meta-analysis CSII vs. MDI Type 2 Diabetes</brief_title>
	<detailed_description>The investigator identify randomise controlled trial without language restriction meet inclusion criterion search Cochrane database , Ovid Medline , Google Scholar source . The investigator exclude observational study , short-term trial &lt; 2 month duration , study pregnant diabetic subject , newly diagnose type 2 diabetes , trial type 1 diabetes extension previous study . Data individual participant obtain directly trialists funding sponsor hold trial data include age , sex , duration diabetes , treatment group , baseline final HbA1c , baseline final insulin dose , baseline final BMI . A 'two-step ' meta-analysis perform estimate overall mean difference HbA1c , insulin dose weight/BMI trial . Then , 'one-step ' meta-regression analysis conduct create single large dataset individual patient data . Determinants final HbA1c , BMI/weight insulin dose explore use Bayesian approach covariates include baseline HbA1c , age , diabetes duration , BMI , insulin dose interaction covariates .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>RCTs CSII vs. MDI type 2 diabetes , study duration least 2 month , nonpregnant Type 1 diabetes , study &lt; 2 month duration , pregnant woman , newly diagnose type 2 diabetes extension previous study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Continuous subcutaneous insulin infusion</keyword>
	<keyword>Meta-analysis</keyword>
	<keyword>Insulin pump therapy</keyword>
	<keyword>Multiple daily insulin injection</keyword>
</DOC>